A
$ Value
$0
Shares
688,000
Price
$0
Filed
Feb 5
Insider
Name
Zeskind Benjamin J.
Title
PRESIDENT AND CEO
CIK
0001870062
Roles
Director
Officer
Transaction Details
Transaction Date
2026-02-03
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
688,000
Footnotes
The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030.
Filing Info
Zeskind Benjamin J.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | IMRX | A | $0 |
| 2025-07-02 | IMRX | ▲ | $25K |
| 2025-07-01 | IMRX | ▲ | $10K |
| 2025-06-18 | IMRX | ▲ | $50K ★ |
Other Insiders at IMRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Matushansky Igor
Chief Medical Officer
|
— | — | 2026-02-03 |
|
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
|
— | — | 2026-02-03 |
|
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-03 |
|
Morales Mallory
SVP Finance, CAO
|
— | — | 2026-02-03 |
|
Neufeld Leah R
CHIEF PEOPLE OFFICER
|
— | — | 2026-02-03 |
|
Brakewood Harold Eugene
Chief Business Officer
|
— | — | 2026-02-03 |